10-75038050-C-A
Variant summary
Our verdict is Likely pathogenic. Variant got 6 ACMG points: 6P and 0B. PM2PP3_Strong
The NM_001003892.3(DUSP29):c.449G>T(p.Gly150Val) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000753 in 1,461,304 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 12/21 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001003892.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DUSP29 | NM_001003892.3 | c.449G>T | p.Gly150Val | missense_variant | 4/4 | ENST00000338487.6 | NP_001003892.1 | |
DUSP29 | NM_001384909.1 | c.449G>T | p.Gly150Val | missense_variant | 5/5 | NP_001371838.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DUSP29 | ENST00000338487.6 | c.449G>T | p.Gly150Val | missense_variant | 4/4 | 1 | NM_001003892.3 | ENSP00000340609 | P1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.0000199 AC: 5AN: 250800Hom.: 0 AF XY: 0.0000295 AC XY: 4AN XY: 135628
GnomAD4 exome AF: 0.00000753 AC: 11AN: 1461304Hom.: 0 Cov.: 31 AF XY: 0.00000688 AC XY: 5AN XY: 726950
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 10, 2023 | The c.449G>T (p.G150V) alteration is located in exon 3 (coding exon 3) of the DUPD1 gene. This alteration results from a G to T substitution at nucleotide position 449, causing the glycine (G) at amino acid position 150 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at